Schizencephaly: Etiopathogenesis, Classification, Therapeutic, and Rehabilitative Approach
Journal of Pediatric Neurology · 01.10.2024 · 22 (05) · 341-346
DOI: 10.1055/s-0044-1786793 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pediatric Neurology, erschienen am 01.10.2024. Verfasst von Monica Tosto und 9 weiteren Autor:innen. Die Arbeit nennt 75 Literaturangaben.
Abstract (Originalsprache)
Schizencephaly is an uncommon anomaly in neuronal migration characterized by complete clefts that extend from the pia mater to the ependymal surface of the ventricular system. These clefts are encompassed by displaced gray matter and filled with cerebrospinal fluid. Typically, they are found most often in the frontal lobe or the area around the lateral sulcus and can occur on one or both sides. The size, location, and type of these clefts carry significant clinical and prognostic implications. Moreover, they are frequently associated with other central nervous system malformations, including the absence of the septum pellucidum, septo-optic dysplasia, optic nerve hypoplasia, pachygyria, polymicrogyria, cortical dysplasia, heterotopia, and dysplasia of the corpus callosum. Occurrence of schizencephaly is almost always sporadic but its etiopathogenesis is yet to be fully understood. Most likely environmental factors, including exposure to teratogens, viral infections, and maternal factors, operate jointly with genetic defects. To date COL4A1, EMX2, SHH, and SIX3 are the genes identified as possible pathogenetic target. It is interesting to notice that schizencephaly is commonly seen in abandoned or adopted children, as proof of causative effect of intrautero insults. Clinical presentations widely vary and symptoms include a spectrum of cognitive impairment, limb paresis/tetraparesis, and epileptic seizures either with early or late onset; anyway, none of these symptoms is ever-present and patients with schizencephaly can also have normal neurocognitive and motor development. Diagnostic gold standard for schizencephaly is magnetic resonance imaging, which allows to identify and characterize typical clefts. Treatment of schizencephaly is symptomatic and supportive and depends on the severity of morbidity resulting from the malformation. Therapy includes antiepileptic drugs, psychomotor rehabilitation, and in selected cases surgical approach.
Zitieren
APA
Tosto, M., Fichera, V., Zanghì, A., Praticò, A. D., Vecchio, M., Palmucci, S., Belfiore, G., Foti, P., Napoli, C. D., & Polizzi, A. (2024). Schizencephaly: Etiopathogenesis, Classification, Therapeutic, and Rehabilitative Approach. Journal of Pediatric Neurology, 22(05), 341-346. https://doi.org/10.1055/s-0044-1786793
Vancouver
Tosto M, Fichera V, Zanghì A, Praticò AD, Vecchio M, Palmucci S, et al. Schizencephaly: Etiopathogenesis, Classification, Therapeutic, and Rehabilitative Approach. Journal of Pediatric Neurology. 2024;22(05):341-346. doi:10.1055/s-0044-1786793
BibTeX
@article{Tosto2024,
author = {Tosto, Monica and Fichera, Valeria and Zanghì, Antonio and Praticò, Andrea D. and Vecchio, Michele and Palmucci, Stefano and Belfiore, Giuseppe and Foti, Pietro and Napoli, Claudia Di and Polizzi, Agata},
title = {Schizencephaly: Etiopathogenesis, Classification, Therapeutic, and Rehabilitative Approach},
journal = {Journal of Pediatric Neurology},
year = {2024},
volume = {22},
number = {05},
pages = {341--346},
doi = {10.1055/s-0044-1786793}
}
EUVIMED